Advances in the management of cardiovascular risk for patients with type 2 diabetes: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes

Advances in the management of cardiovascular risk for patients with type 2 diabetes: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes

Guntram Schernthaner,1 Sarah Jarvis,2 Chaim Lotan,3 Martin Prázný,4 Christoph Wanner,5 Thomas C Wascher6 1Department of Medicine, Rudolfstiftung Hospital, Vienna, Austria; 2Richford Gate Medical Practice, London, UK; 3Cardiovascular Division, Heart Institute, Hadassah-Hebrew U...

Full description

Bibliographic Details
Main Authors: Schernthaner G, Jarvis S, Lotan C, Prázný M, Wanner C, Wascher TC
Format: Article
Language:English
Published: Dove Medical Press 2017-01-01
Series:Therapeutics and Clinical Risk Management
Subjects:
Type 2 diabetes
Cardiovascular risk
SGLT2 inhibitor
CVOTs
Empagliflozin
Online Access:https://www.dovepress.com/advances-in-the-management-of-cardiovascular-risk-for-patients-with-ty-peer-reviewed-article-TCRM

Internet

https://www.dovepress.com/advances-in-the-management-of-cardiovascular-risk-for-patients-with-ty-peer-reviewed-article-TCRM

Similar Items